CMS Shares Prescription Drug Inflation Rebate Program Guidance

Centers for Medicare and Medicaid Services CMS released two highly-anticipated guidance documents detailing the agency’s proposed implementation of the Medicare Part B and Medicare Part D Prescription Drug Inflation Rebate Programs.

Related Keywords

,Department Of Justice ,Partd Rebate Program ,Partb Rebate Program ,Rebate Program ,Centers For Medicare ,Supplementary Medical Insurance Trust Fund ,Public Health Service ,Drug Negotiation Program ,B Drug Pricing Program ,Medicaid Services ,Medicaid Drug Rebate Program ,Prescription Drug Inflation Rebate Programs ,Rebate Programs ,Inflation Reduction Act ,Affordable Care ,Key Guidance ,Social Security Act ,Medicare Prescription Drug Account ,Federal Supplementary Medical Insurance Trust ,Guidance Final ,Partd Rebate Programs ,Drug Pricing ,Medicare Advantage ,Partb Inflation Rebate ,Partd Inflation Rebate Comments ,Consumer Price Index ,Urban Consumers ,Emergency Use Authorization ,Healthcare Common Procedure Coding System ,Coinsurance Rates ,Key Dates ,Drug Pricing Program ,Traditional Medicare ,Medicare Part ,Medicaid Drug Rebate ,Medicare Rebate ,Press Release ,Initial Guidance ,Public Health Service Act ,Security Act ,Partb Inflation Rebates ,Abbreviated New Drug Application ,Partd Inflation Rebates ,Legal ,Business ,Government ,Centers For Medicare And Medicaid Services ,Medicare Part B ,Medicare Part D ,S Healthcare Legislation 2023 ,